Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$209.01 - $232.56 $385,414 - $428,840
1,844 New
1,844 $402,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $314,178 - $402,199
1,534 Added 110.12%
2,927 $599,000
Q2 2022

Aug 09, 2022

BUY
$213.86 - $277.87 $85,544 - $111,148
400 Added 40.28%
1,393 $326,000
Q1 2022

May 11, 2022

SELL
$259.82 - $298.18 $39,752 - $45,621
-153 Reduced 13.35%
993 $262,000
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $15,752 - $18,224
58 Added 5.33%
1,146 $360,000
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $299,004 - $335,473
1,088 New
1,088 $306,000
Q1 2020

May 12, 2020

SELL
$104.32 - $195.28 $421,452 - $788,931
-4,040 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$163.48 - $173.61 $234,757 - $249,303
-1,436 Reduced 26.22%
4,040 $683,000
Q3 2019

Nov 12, 2019

SELL
$159.77 - $178.1 $253,714 - $282,822
-1,588 Reduced 22.48%
5,476 $920,000
Q2 2019

Aug 06, 2019

BUY
$144.16 - $172.9 $1.02 Million - $1.22 Million
7,064 New
7,064 $1.22 Million
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $527,580 - $666,619
-4,265 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$120.82 - $174.09 $2.17 Million - $3.13 Million
-17,952 Reduced 80.8%
4,265 $539,000
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $3.73 Million - $4.18 Million
22,217 New
22,217 $3.86 Million
Q2 2018

Aug 09, 2018

SELL
$160.33 - $189.41 $551,695 - $651,759
-3,441 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$161.53 - $178.11 $141,177 - $155,668
874 Added 34.05%
3,441 $557,000
Q4 2017

Feb 14, 2018

SELL
$147.99 - $163.95 $375,894 - $416,433
-2,540 Reduced 49.74%
2,567 $409,000
Q3 2017

Nov 20, 2017

BUY
$149.47 - $160.56 $763,343 - $819,979
5,107
5,107 $771,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.